Filligent
creating global health choices
HOME

 

Featuring Filligent Intelligent Filtration

It all starts with a sneeze...

Watch this video to learn more about Filligent's powerful and preventative health technologies.

 

 

Updated 14-May-2012

  • Taiwan: Outbreak of Highly Pathogenic H5N2 Bird Flu

  • Australia / USA: H1N1 Resistance to Oseltamivir May Spread

  • Brazil / Russia / India / China: Lifestyle and Infectious Diseases Encourage In Vitro Diagnostics Market in Emerging Countries

The simplest and easiest way to prevent catching Flu is to protect yourself. The BioFriend™ BioMask™ can rapidly inactivate 19 strains of influenza viruses, measles, TB and many other pathogens.

 

ICU Infections

  • In-hospital mortality in ICU patients with a Hospital-Acquired Infection (HAI) was 4 times higher than in those without a HAI

  • Length of ICU stay of in-patients with a HAI doubled, from average 8.1 days to 15.8 days

  • Based on the analysis of direct variable costs & fixed overhead costs, these infections cost an extra $16,000 per ICU stay — from $21,500 for a patient without a HAI to $37,500 for a patient with a HAI

  • Bloodstream infection was the greatest driver of mortality (24.7%), followed by hospital-acquired pneumonia (16.7%), and surgical-site infection (10.9%)

Source 1 | Source 2 

HONG KONG AIR POLLUTION INDEX

Current Air Pollution Index: General Stations 25 to 42; Roadside Stations 76 to 89
Forecast for Today's Air Pollution Index: General Station 25 to 45; Roadside Station 70 to 95

CURAD BIOMASK™ AVAILABLE AT MAJOR U.S. RETAILERS

Medline introduces nation's first U.S. antiviral face mask that inactivates 99.99% of tested flu viruses

77% of Australian dentists would recommend Filligent's BioMask™ Antimicrobial Mask

Henry Schein Halas has undertaken a customer survey of the BioMask™ with a resounding 77% of those surveyed saying they would recommend the BioMask™ to other people.

FILLIGENT FEATURED...

 
INTERNATIONAL DENTISTRY MAGAZINE
 
A research paper on the efficacy of the BioMask, entitled Pathogen Inactivation and Filtration Efficacy of a New Anti‐Microbial and Anti‐Viral Surgical Facemask and N95 against Dentistry‐Associated Microorganisms was recently published in the March edition of International Dentistry, Australasia.

 

 
 
 IN-HOUSE ENTREPRENEURSHIP
 
Filligent's CEO and co-founding entrepreneur, Melissa Mowbray-d'Arbela, is featured in the No. 1 bestselling book in Hong Kong, Ladies Who Launch in Hong Kong by Maseena Ziegler. As featured on Forbes.com, the book highlights Melissa's journey from architect to lawyer to investment banker to entrepreneur. 
 
Melissa was also recently profiled for The Story Exchange, a video project which showcases the success stories of women entrepreneurs, and is in the spotlight for this article on Women 2.0.